CIK 1940272
ADAR1 Capital Management, LLC
Institutional 13F holdings & portfolio
Holdings
512
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 401–450 of 512
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| SGRY | SURGERY PARTNERS INC | 20K | $100K–$500K | SH |
| SGRY | SURGERY PARTNERS INC | 20K | $100K–$500K | SH |
| JD | JD.COM INC | 10K | $100K–$500K | SH |
| JD | JD.COM INC | 10K | $100K–$500K | SH |
| PCAPU | PROCAP ACQUISITION CORP | 27K | $100K–$500K | SH |
| PCAPU | PROCAP ACQUISITION CORP | 27K | $100K–$500K | SH |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 4K | $100K–$500K | SH |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 4K | $100K–$500K | SH |
| IDXX | IDEXX LABS INC | 400 | $100K–$500K | SH |
| IDXX | IDEXX LABS INC | 400 | $100K–$500K | SH |
| SPRO | SPERO THERAPEUTICS INC | 114K | $100K–$500K | SH |
| SPRO | SPERO THERAPEUTICS INC | 114K | $100K–$500K | SH |
| CATX | PERSPECTIVE THERAPEUTICS INC | 95K | $100K–$500K | SH |
| CATX | PERSPECTIVE THERAPEUTICS INC | 95K | $100K–$500K | SH |
| IMMX | IMMIX BIOPHARMA INC | 50K | $100K–$500K | SH |
| IMMX | IMMIX BIOPHARMA INC | 50K | $100K–$500K | SH |
| JSPR | JASPER THERAPEUTICS INC | 140K | $100K–$500K | SH |
| JSPR | JASPER THERAPEUTICS INC | 140K | $100K–$500K | SH |
| SNDX | SYNDAX PHARMACEUTICALS INC | 12K | $100K–$500K | SH |
| SNDX | SYNDAX PHARMACEUTICALS INC | 12K | $100K–$500K | SH |
| OGN | ORGANON & CO | 35K | $100K–$500K | SH |
| OGN | ORGANON & CO | 35K | $100K–$500K | SH |
| ANNX | ANNEXON INC | 48K | $100K–$500K | SH |
| ANNX | ANNEXON INC | 48K | $100K–$500K | SH |
| PEPG | PEPGEN INC | 37K | $100K–$500K | SH |
| PEPG | PEPGEN INC | 37K | $100K–$500K | SH |
| EOLS | EVOLUS INC | 36K | $100K–$500K | SH |
| EOLS | EVOLUS INC | 36K | $100K–$500K | SH |
| ACHV | ACHIEVE LIFE SCIENCES INC | 48K | $100K–$500K | SH |
| ACHV | ACHIEVE LIFE SCIENCES INC | 48K | $100K–$500K | SH |
| BCAX | BICARA THERAPEUTICS INC | 14K | $100K–$500K | SH |
| BCAX | BICARA THERAPEUTICS INC | 14K | $100K–$500K | SH |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 10K | $100K–$500K | SH (Call) |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 10K | $100K–$500K | SH (Call) |
| RXST | RXSIGHT INC | 22K | $100K–$500K | SH |
| RXST | RXSIGHT INC | 22K | $100K–$500K | SH |
| MIST | MILESTONE PHARMACEUTICALS IN | 100K | $100K–$500K | SH |
| MIST | MILESTONE PHARMACEUTICALS IN | 100K | $100K–$500K | SH |
| WHWK | WHITEHAWK THERAPEUTICS INC | 78K | $100K–$500K | SH |
| WHWK | WHITEHAWK THERAPEUTICS INC | 78K | $100K–$500K | SH |
| TRAW | TRAWS PHARMA INC | 154K | $100K–$500K | SH |
| TRAW | TRAWS PHARMA INC | 154K | $100K–$500K | SH |
| KALV | KALVISTA PHARMACEUTICALS INC | 10K | $100K–$500K | SH |
| KALV | KALVISTA PHARMACEUTICALS INC | 10K | $100K–$500K | SH |
| OTLK | OUTLOOK THERAPEUTICS INC | 100K | $100K–$500K | SH (Put) |
| OTLK | OUTLOOK THERAPEUTICS INC | 100K | $100K–$500K | SH (Put) |
| RLMD | RELMADA THERAPEUTICS INC | 31K | $100K–$500K | SH |
| RLMD | RELMADA THERAPEUTICS INC | 31K | $100K–$500K | SH |
| VYNE | VYNE THERAPEUTICS INC | 254K | $100K–$500K | SH |
| VYNE | VYNE THERAPEUTICS INC | 254K | $100K–$500K | SH |